Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study

Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the pr...

Full description

Saved in:
Bibliographic Details
Published inBMC urology Vol. 15; no. 1; p. 40
Main Authors Chang, Ching-Hsin, Lin, Tzu-Ping, Chang, Yen-Hwa, Huang, William J S, Lin, Alex T L, Chen, Kuang-Kuo
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 09.05.2015
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student's t-test and analysis of variance. The ages (mean ± SD) of the patients were 76.1 ± 9.4 and 72.6 ± 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 ± 5.0 and 6.5 ± 3.8, respectively, in the ThuVEP group and 18.2 ± 4.5 and 6.2 ± 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients. ISRCTN registry with study ID ISRCTN52339705 . Date assigned: 06/03/2015.
AbstractList Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student's t-test and analysis of variance. The ages (mean [+ or -] SD) of the patients were 76.1 [+ or -] 9.4 and 72.6 [+ or -] 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 [+ or -] 5.0 and 6.5 [+ or -] 3.8, respectively, in the ThuVEP group and 18.2 [+ or -] 4.5 and 6.2 [+ or -] 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients.
BACKGROUNDProstate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP).METHODSWe prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student's t-test and analysis of variance.RESULTSThe ages (mean ± SD) of the patients were 76.1 ± 9.4 and 72.6 ± 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 ± 5.0 and 6.5 ± 3.8, respectively, in the ThuVEP group and 18.2 ± 4.5 and 6.2 ± 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group.CONCLUSIONSOne year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients.TRIAL REGISTRATIONISRCTN registry with study ID ISRCTN52339705 . Date assigned: 06/03/2015.
Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student's t-test and analysis of variance. The ages (mean ± SD) of the patients were 76.1 ± 9.4 and 72.6 ± 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 ± 5.0 and 6.5 ± 3.8, respectively, in the ThuVEP group and 18.2 ± 4.5 and 6.2 ± 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients. ISRCTN registry with study ID ISRCTN52339705 . Date assigned: 06/03/2015.
Background Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). Methods We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student's t-test and analysis of variance. Results The ages (mean [+ or -] SD) of the patients were 76.1 [+ or -] 9.4 and 72.6 [+ or -] 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 [+ or -] 5.0 and 6.5 [+ or -] 3.8, respectively, in the ThuVEP group and 18.2 [+ or -] 4.5 and 6.2 [+ or -] 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. Conclusions One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients. Trial registration ISRCTN registry with study ID ISRCTN52339705. Date assigned: 06/03/2015. Keywords: Benign prostate enlargement, Quanta thulium surgical laser system, Thulium laser, Vapoenucleation
ArticleNumber 40
Audience Academic
Author Chang, Yen-Hwa
Huang, William J S
Chang, Ching-Hsin
Lin, Tzu-Ping
Chen, Kuang-Kuo
Lin, Alex T L
Author_xml – sequence: 1
  givenname: Ching-Hsin
  surname: Chang
  fullname: Chang, Ching-Hsin
  email: jossp1029@gmail.com, jossp1029@gmail.com, jossp1029@gmail.com
  organization: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. jossp1029@gmail.com
– sequence: 2
  givenname: Tzu-Ping
  surname: Lin
  fullname: Lin, Tzu-Ping
  email: tplin63@gmail.com, tplin63@gmail.com, tplin63@gmail.com
  organization: Shu-Tien Urological Science Research Center, Taipei, Taiwan. tplin63@gmail.com
– sequence: 3
  givenname: Yen-Hwa
  surname: Chang
  fullname: Chang, Yen-Hwa
  email: yhchang@vghtpe.gov.tw, yhchang@vghtpe.gov.tw, yhchang@vghtpe.gov.tw
  organization: Shu-Tien Urological Science Research Center, Taipei, Taiwan. yhchang@vghtpe.gov.tw
– sequence: 4
  givenname: William J S
  surname: Huang
  fullname: Huang, William J S
  email: jshuang@vghtpe.gov.tw, jshuang@vghtpe.gov.tw, jshuang@vghtpe.gov.tw
  organization: Shu-Tien Urological Science Research Center, Taipei, Taiwan. jshuang@vghtpe.gov.tw
– sequence: 5
  givenname: Alex T L
  surname: Lin
  fullname: Lin, Alex T L
  email: lin.alextl@gmail.com, lin.alextl@gmail.com, lin.alextl@gmail.com
  organization: Shu-Tien Urological Science Research Center, Taipei, Taiwan. lin.alextl@gmail.com
– sequence: 6
  givenname: Kuang-Kuo
  surname: Chen
  fullname: Chen, Kuang-Kuo
  email: kkchen@vghtpe.gov.tw, kkchen@vghtpe.gov.tw, kkchen@vghtpe.gov.tw
  organization: Shu-Tien Urological Science Research Center, Taipei, Taiwan. kkchen@vghtpe.gov.tw
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25956819$$D View this record in MEDLINE/PubMed
BookMark eNptUUtrFTEYDVKxD_0BbiTgxk1q3pNxIZTio1DoproSQmbmy72RTDJOZiz335vLraWFkkXCdx6cfOcUHaWcAKG3jJ4zZvTHwrhpJaFMEUoFJ80LdMJkwwiXLT169D5Gp6X8ppQ1RulX6JirVmnD2hP066ebMqS1j-CWkBPOHi9bwNOcy-IWwGsJaYMd3obNlkz5DuaKrzGsI46uwPypYjUV2YGbsc8x5juyTrgs67B7jV56Fwu8ub_P0I-vX24vv5Prm29XlxfXpFdCL6QTolNDzWaE1L2krnWGcw3O04obYXSnqQLmWOcFk0NjBqnUoCSXg_ROiDP0-eA7rd0IQw9pmV200xxGN-9sdsE-RVLY2k3-a6UURpq9wYd7gzn_WaEsdgylhxhdgrwWy7Thkgut2kp9f6BuXAQbks_Vsd_T7YWSTApaA1fW-TOsegYYQ1_35UOdPxGwg6Cviy8z-If0jNp92fZQtq1l233Ztqmad4-__aD43674B3Gaplk
CitedBy_id crossref_primary_10_1097_MD_0000000000030235
crossref_primary_10_1007_s10103_020_03227_4
crossref_primary_10_1016_j_urols_2016_03_006
crossref_primary_10_1016_j_urology_2019_10_022
crossref_primary_10_1002_pros_24717
crossref_primary_10_1007_s00345_021_03704_7
crossref_primary_10_1016_j_juro_2018_05_048
crossref_primary_10_1177_2051415819879667
crossref_primary_10_1186_s12894_019_0437_9
crossref_primary_10_1016_j_urology_2018_09_007
crossref_primary_10_1038_s41391_019_0135_4
crossref_primary_10_1177_1756287216632429
crossref_primary_10_21886_2308_6424_2023_11_4_44_51
crossref_primary_10_3390_life13102077
crossref_primary_10_1007_s11884_021_00627_2
crossref_primary_10_1007_s00345_019_02968_4
crossref_primary_10_1016_j_urols_2016_11_008
crossref_primary_10_2147_CIA_S414799
crossref_primary_10_1007_s00345_021_03825_z
Cites_doi 10.1016/j.juro.2009.04.008
10.1016/j.juro.2008.03.058
10.1007/s11255-009-9572-7
10.1111/j.1464-410X.2010.09229.x
10.1097/MOU.0b013e32834120d7
10.1016/S0022-5347(01)63011-8
10.1007/s00345-008-0370-0
10.1097/MOU.0b013e32834100b3
10.1097/MOU.0b013e3283411455
10.1016/j.urology.2008.12.052
10.1002/lsm.20126
10.1111/j.1464-410X.1995.tb07347.x
10.1016/j.juro.2009.11.034
10.1007/s00345-009-0503-0
10.1111/j.1464-410X.2009.08516.x
10.1245/s10434-009-0896-4
10.1016/S0022-5347(05)68186-4
10.1038/sj.ijir.3900401
10.1016/j.eururo.2007.08.036
10.1007/s00345-010-0561-3
10.1111/j.1464-410X.2007.07341.x
10.1007/s00345-010-0522-x
10.1016/j.eururo.2007.05.019
10.1089/end.2005.19.25
10.1111/j.1464-410X.2009.08978.x
10.1007/s00345-007-0171-x
ContentType Journal Article
Copyright COPYRIGHT 2015 BioMed Central Ltd.
Chang et al.; licensee BioMed Central. 2015
Copyright_xml – notice: COPYRIGHT 2015 BioMed Central Ltd.
– notice: Chang et al.; licensee BioMed Central. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1186/s12894-015-0032-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2490
EndPage 40
ExternalDocumentID A541430838
10_1186_s12894_015_0032_7
25956819
Genre Randomized Controlled Trial
Journal Article
Comparative Study
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
4.4
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
AFGXO
7X8
5PM
ID FETCH-LOGICAL-c536t-b33b5d1788346c40a9a8226eaf05368386b605e1a1bf314d78d455d5424d4fa33
IEDL.DBID RPM
ISSN 1471-2490
IngestDate Tue Sep 17 21:23:48 EDT 2024
Sat Oct 05 06:08:23 EDT 2024
Wed Aug 14 18:53:47 EDT 2024
Tue Aug 13 05:21:55 EDT 2024
Thu Sep 12 17:55:50 EDT 2024
Sat Sep 28 08:11:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-b33b5d1788346c40a9a8226eaf05368386b605e1a1bf314d78d455d5424d4fa33
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438483/
PMID 25956819
PQID 1682423659
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4438483
proquest_miscellaneous_1682423659
gale_infotracmisc_A541430838
gale_infotracacademiconefile_A541430838
crossref_primary_10_1186_s12894_015_0032_7
pubmed_primary_25956819
PublicationCentury 2000
PublicationDate 2015-May-09
2015-05-09
20150509
PublicationDateYYYYMMDD 2015-05-09
PublicationDate_xml – month: 05
  year: 2015
  text: 2015-May-09
  day: 09
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC urology
PublicationTitleAlternate BMC Urol
PublicationYear 2015
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References 18086107 - BJU Int. 2008 Jan;101(1):131-42
20204378 - World J Urol. 2010 Apr;28(2):163-8
19394500 - Urology. 2009 May;73(5):1042-8
19184038 - World J Urol. 2009 Aug;27(4):541-5
20063164 - World J Urol. 2010 Feb;28(1):45-51
10524887 - J Urol. 1999 Nov;162(5):1640-4
10404287 - Int J Impot Res. 1999 Jun;11(3):177
21099689 - Curr Opin Urol. 2011 Jan;21(1):31-5
17566639 - Eur Urol. 2008 Feb;53(2):382-89
20091426 - Ann Surg Oncol. 2010 May;17(5):1422-8
15735378 - J Endourol. 2005 Jan-Feb;19(1):25-31
9628595 - J Urol. 1998 Jul;160(1):12-6; discussion 16-7
19338541 - BJU Int. 2009 Aug;104(4):434-6
20184573 - BJU Int. 2010 Sep;106(6):822-6
18499179 - J Urol. 2008 Jul;180(1):246-9
19535100 - J Urol. 2009 Aug;182(2):626-32
16405847 - Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3225-8
15662624 - Lasers Surg Med. 2005 Jan;36(1):52-6
19472910 - Zhonghua Nan Ke Xue. 2009 Apr;15(4):346-9
21099690 - Curr Opin Urol. 2011 Jan;21(1):36-41
19449121 - Int Urol Nephrol. 2010 Mar;42(1):7-12
7537604 - Br J Urol. 1995 Mar;75(3):347-53
21045706 - Curr Opin Urol. 2011 Jan;21(1):42-8
20092844 - J Urol. 2010 Mar;183(3):1105-9
20577744 - World J Urol. 2011 Apr;29(2):211-6
17530258 - World J Urol. 2007 Jun;25(3):257-62
19863522 - BJU Int. 2010 May;105(10):1429-33
17869409 - Eur Urol. 2008 Jan;53(1):160-6
RC Flanigan (32_CR4) 1998; 160
T Bach (32_CR16) 2007; 25
Q Shao (32_CR17) 2009; 15
T Bach (32_CR24) 2010; 28
SJ Xia (32_CR19) 2008; 53
C Jeldres (32_CR7) 2009; 182
M Morgan (32_CR27) 2009; 104
A Descazeaud (32_CR28) 2011; 29
RJ Hoekstra (32_CR5) 2010; 106
E Gnessin (32_CR12) 2011; 21
KL Lo (32_CR1) 2010; 42
P Gilling (32_CR21) 2008; 101
RM Kuntz (32_CR11) 2008; 53
PJ Gilling (32_CR9) 1999; 162
J Placer (32_CR13) 2009; 73
O Reich (32_CR8) 2008; 180
G Robert (32_CR3) 2011; 21
SJ Xia (32_CR18) 2005; 85
NM Fried (32_CR14) 2005; 19
RM Merrill (32_CR2) 2010; 17
JE Oesterling (32_CR20) 1995; 75
RD Smith (32_CR23) 2011; 21
NM Fried (32_CR15) 2005; 36
T Bach (32_CR26) 2009; 27
AE Krambeck (32_CR10) 2010; 183
N Masumori (32_CR6) 2010; 105
JA Vroege (32_CR22) 1999; 11
TR Herrmann (32_CR25) 2010; 28
References_xml – volume: 182
  start-page: 626
  year: 2009
  ident: 32_CR7
  publication-title: J Urol
  doi: 10.1016/j.juro.2009.04.008
  contributor:
    fullname: C Jeldres
– volume: 180
  start-page: 246
  year: 2008
  ident: 32_CR8
  publication-title: J Urol
  doi: 10.1016/j.juro.2008.03.058
  contributor:
    fullname: O Reich
– volume: 42
  start-page: 7
  year: 2010
  ident: 32_CR1
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-009-9572-7
  contributor:
    fullname: KL Lo
– volume: 106
  start-page: 822
  year: 2010
  ident: 32_CR5
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2010.09229.x
  contributor:
    fullname: RJ Hoekstra
– volume: 21
  start-page: 31
  year: 2011
  ident: 32_CR12
  publication-title: Curr Opin Urol
  doi: 10.1097/MOU.0b013e32834120d7
  contributor:
    fullname: E Gnessin
– volume: 160
  start-page: 12
  year: 1998
  ident: 32_CR4
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)63011-8
  contributor:
    fullname: RC Flanigan
– volume: 27
  start-page: 541
  year: 2009
  ident: 32_CR26
  publication-title: World J Urol
  doi: 10.1007/s00345-008-0370-0
  contributor:
    fullname: T Bach
– volume: 21
  start-page: 42
  year: 2011
  ident: 32_CR3
  publication-title: Curr Opin Urol
  doi: 10.1097/MOU.0b013e32834100b3
  contributor:
    fullname: G Robert
– volume: 21
  start-page: 36
  year: 2011
  ident: 32_CR23
  publication-title: Curr Opin Urol
  doi: 10.1097/MOU.0b013e3283411455
  contributor:
    fullname: RD Smith
– volume: 85
  start-page: 3225
  year: 2005
  ident: 32_CR18
  publication-title: Zhonghua Yi Xue Za Zhi
  contributor:
    fullname: SJ Xia
– volume: 73
  start-page: 1042
  year: 2009
  ident: 32_CR13
  publication-title: Urology
  doi: 10.1016/j.urology.2008.12.052
  contributor:
    fullname: J Placer
– volume: 36
  start-page: 52
  year: 2005
  ident: 32_CR15
  publication-title: Lasers Surg Med
  doi: 10.1002/lsm.20126
  contributor:
    fullname: NM Fried
– volume: 75
  start-page: 347
  year: 1995
  ident: 32_CR20
  publication-title: Br J Urol
  doi: 10.1111/j.1464-410X.1995.tb07347.x
  contributor:
    fullname: JE Oesterling
– volume: 183
  start-page: 1105
  year: 2010
  ident: 32_CR10
  publication-title: J Urol
  doi: 10.1016/j.juro.2009.11.034
  contributor:
    fullname: AE Krambeck
– volume: 28
  start-page: 45
  year: 2010
  ident: 32_CR25
  publication-title: World J Urol
  doi: 10.1007/s00345-009-0503-0
  contributor:
    fullname: TR Herrmann
– volume: 104
  start-page: 434
  year: 2009
  ident: 32_CR27
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2009.08516.x
  contributor:
    fullname: M Morgan
– volume: 17
  start-page: 1422
  year: 2010
  ident: 32_CR2
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-009-0896-4
  contributor:
    fullname: RM Merrill
– volume: 162
  start-page: 1640
  year: 1999
  ident: 32_CR9
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)68186-4
  contributor:
    fullname: PJ Gilling
– volume: 11
  start-page: 177
  year: 1999
  ident: 32_CR22
  publication-title: Int J Impot Res
  doi: 10.1038/sj.ijir.3900401
  contributor:
    fullname: JA Vroege
– volume: 53
  start-page: 160
  year: 2008
  ident: 32_CR11
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2007.08.036
  contributor:
    fullname: RM Kuntz
– volume: 29
  start-page: 211
  year: 2011
  ident: 32_CR28
  publication-title: World J Urol
  doi: 10.1007/s00345-010-0561-3
  contributor:
    fullname: A Descazeaud
– volume: 101
  start-page: 131
  year: 2008
  ident: 32_CR21
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2007.07341.x
  contributor:
    fullname: P Gilling
– volume: 28
  start-page: 163
  year: 2010
  ident: 32_CR24
  publication-title: World J Urol
  doi: 10.1007/s00345-010-0522-x
  contributor:
    fullname: T Bach
– volume: 53
  start-page: 382
  year: 2008
  ident: 32_CR19
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2007.05.019
  contributor:
    fullname: SJ Xia
– volume: 15
  start-page: 346
  year: 2009
  ident: 32_CR17
  publication-title: Zhonghua Nan Ke Xue
  contributor:
    fullname: Q Shao
– volume: 19
  start-page: 25
  year: 2005
  ident: 32_CR14
  publication-title: J Endourol
  doi: 10.1089/end.2005.19.25
  contributor:
    fullname: NM Fried
– volume: 105
  start-page: 1429
  year: 2010
  ident: 32_CR6
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2009.08978.x
  contributor:
    fullname: N Masumori
– volume: 25
  start-page: 257
  year: 2007
  ident: 32_CR16
  publication-title: World J Urol
  doi: 10.1007/s00345-007-0171-x
  contributor:
    fullname: T Bach
SSID ssj0017856
Score 2.18214
Snippet Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical...
Background Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This...
BACKGROUNDProstate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 40
SubjectTerms Age Factors
Aged
Aged, 80 and over
Analysis
Follow-Up Studies
Humans
Laser Therapy - methods
Lasers in medicine
Lasers, Solid-State - therapeutic use
Male
Prospective Studies
Prostatic Hyperplasia - complications
Prostatic Hyperplasia - diagnosis
Prostatic Hyperplasia - surgery
Risk Assessment
Severity of Illness Index
Sex Factors
Thulium
Time Factors
Transurethral Resection of Prostate - methods
Treatment Outcome
Urinary Bladder Neck Obstruction - etiology
Urinary Bladder Neck Obstruction - physiopathology
Urinary Bladder Neck Obstruction - surgery
Urinary Retention - etiology
Urinary Retention - physiopathology
Urinary Retention - surgery
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rS90wFA9OYezLmO51nUoGg8Egm2keTQciIooI7tPu8MMg5NE4wbX13ls2__ud0_aqHSL02ylNOI_kd5qT3yHkg_fSG51yFrzPIUGJnjmeItNIvi_xh3LA-85n3_TJVJ6eq_MVsmxvNShw_mBqh_2kprOrz3-vb_Yh4Pe6gDf6yxzWWCS45YqBjwJgfELWMgmJOlbyybtDhdyo_rJRzhlkHctDzgc_Mdqm_l-s7-1W40rKe1vT8QvyfMCU9KB3gnWyUlYb5OnZcGr-kvz84Zq6rJC5uLMDrRMF3EcbvPEBWJNi8fsFdRS5i1mDfdNA3l5dtr8pgOty9hVkdVWyGwgLmsBz6j-sbWhHTfuKTI-Pvh-esKGrAgtK6AXzQngVQRlGSB3kriscgARdugTxqI0w2kOKU3LHfRJcxtxEqVRUMpNRJifEa7JawZhvCXUyJMhIYgoAYzgWTAF6UbEIXBdZ2FUT8mmpRNv05Bm2SzqMtr3GLWgc6Ukzm0_IR1SzRVODLoMb7gfAUEhRZQ-wYbkAxGgmZGv0JgREGInfLw1lUYRVZFVZt3PLtUH4qFUxIW96w93OC9JA5GIDST4y6e0LyMM9llSXvzo-bimFkUZsPj6td-RZ1vkXPMUWWV3M2nIbAM3C73Ru-g9MSPAb
  priority: 102
  providerName: Scholars Portal
Title Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
URI https://www.ncbi.nlm.nih.gov/pubmed/25956819
https://search.proquest.com/docview/1682423659
https://pubmed.ncbi.nlm.nih.gov/PMC4438483
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9RAEB7aCuIX8d1oPVYQBGF7ze1LNn5rS0sRrpRi5RBh2ZdED3pJaC-I_96ZXFIufhTCfpmEhNknu8_szjwL8MF76Y0uMx68zzBAiZ67tIxck_i-pAXlQPXO8wt9fi2_LNRiB9RQC9Ml7Qe_PKhuVgfV8leXW9mswnTIE5tezk-kFEYaMd2FXQToEKL3WweZUbrfvkyNnt7hAEzqt6niCGBkkyT_q6hIjsR1tuaif0fkrSlpnC65Nf-cPYHHPXFkR5sPfAo7RfUMHs77rfHn8OOba-qiInniztmsLhmSO9ZQWQcSSkYZ7j-ZYyRQzBs6HA3t7c2yXTFk0MXtZ7TVVcH_IPZZifCof_O2YZ3-7Au4Pjv9enLO-6MTeFBCr7kXwquIvjBC6iAPXe6QCejClfjTaSOM9hjHFKlLfSlSGTMTpVJRyZmMsnRCvIS9Ct_5GpiTocSwI5YBuUpKWVFIUVTMQ6rzWThUCXwanGibjUKG7SILo-3G-RadTxqkM5sl8JHcbOnvQV8G1xcB4KtIh8oe0ankAmmhSWB_dCeiPozM74eOsmSiVLGqqNs7m2pDHFGrPIFXm467_66h4xPIRl16fwOJbY8tiMFOdLvH3Jv_fvItPJp1KMQr34e99W1bvENCs_YThPEim8CD49OLy6tJtyyA7VwabK-Ov086gP8F7en5_A
link.rule.ids 230,315,730,783,787,867,888,24330,27936,27937,31732,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qBe2L3x_RqisIgrB3l9uPbHwrxXJqr_jQlj4Iy-4m0aO9JLQXRP96Z_JR7vqmkLdJ2CTzm-xvsjO_BXjnvfRGFwkP3ieYoGSeu7jIuCbxfUk_lAP1O8-P9OxEfjlTZ1ughl6Ytmg_-MWovFiOysXPtrayXobxUCc2_jbfl1IYacT4FtzGeJ3IIUnvFw8So3S_gBkbPb7CTzDp38aKI4SRT5IAsKI2OZLXWZuNbn6T1yalzYLJtRno4D6cDvfeFZ6cj5qVH4U_N2Qd__nhHsC9npOyvc78ELby8hHcmfer7o_h-6mrq7wk5ePWj6wqGPJGVlPHCHJVRsXzP5hjpH3Ma9p3De3NxaJZMiTn-eVHtFVlzn9jWLECkVf94k3NWmnbJ3By8Ol4f8b7XRl4UEKvuBfCqwxfshFSBzlxqUOSoXNXYDxrI4z2mCLlsYt9IWKZJSaTSmVKTmUmCyfEU9guccznwJwMBWY0WRGQBsVUcIXsR2VpiHU6DRMVwYfBO7buxDdsm7QYbTuvWvQqyZtObRLBe_KfpcBEJwXX9xfgUCRxZfdow3OBjNNEsLtxJgZU2DC_HRBgyURVaGVeNVc21obop1ZpBM86RFzf14CoCJINrFyfQDremxZEQKvn3Xv8xX9f-Qbuzo7nh_bw89HXl7AzbaGOR7oL26vLJn-FvGnlX7dR8hc8_Bak
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEF-0QvGL9VmjVVcQBCGXy-0jG7-V6lEfV_rBShFh2UdWD3tJaC8U_eudyaNc-rGQb7Nhk8zM7m-yM78h5I213CoZsthZm0GA4m1s0uBjieT7HH8oO6x3XhzJwxP--VScbrT6apP2nV1OyrPVpFz-bnMr65VLhjyx5HhxwDlTXLGk9iG5Te6Az07lEKj3BwiZErI_xEyVTC5gGUYO3FTEYMaAKZEEWGCpHFLsbOxI19fljY1pnDS5sQvNd8iP4fm75JM_k2ZtJ-7fNWrHG73gfXKvx6Z0vxvygNwqyodke9Gfvj8iP7-buipKZEBu9UmrQAE_0horRwCzUkyi_0UNRQ7kuMb-ayBvzpbNigJIL87fg6wqi_gvuBcNYIHVZdzUtKW4fUxO5h-_HRzGfXeG2Akm17FlzAoPH1oxLh2fmtwA2JCFCeDXUjElLYRKRWpSG1jKfaY8F8ILPuOeB8PYE7JVwpxPCTXcBYhsfHAAh1JMvAIUJHzuUpnP3FRE5N2gIV13JBy6DV6U1J1mNWgWaU5nOovIW9ShRgcFRTnT1xnAVEh1pfex8TkD5KkisjcaCY7lRuLXgxVoFGE2WllUzYVOpUIYKkUekd3OKq6ea7CqiGQje7kagHzeYwlYQcvr3Wv92Y3vfEW2jz_M9ddPR1-ek7uz1trhyvfI1vq8KV4AfFrbl62j_AcDaxkk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vapoenucleation+of+the+prostate+using+a+high-power+thulium+laser%3A+a+one-year+follow-up+study&rft.jtitle=BMC+urology&rft.au=Chang%2C+Ching-Hsin&rft.au=Lin%2C+Tzu-Ping&rft.au=Chang%2C+Yen-Hwa&rft.au=Huang%2C+William+JS&rft.date=2015-05-09&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2490&rft.eissn=1471-2490&rft.volume=15&rft_id=info:doi/10.1186%2Fs12894-015-0032-7&rft.externalDocID=A541430838
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon